N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one

C182H241N23O31 — CID 165035261

IUPACN-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one
SMILESCC(=O)Nc1cccc(N2C(=O)/C(=C3\C(=O)C(c4c(O)n(-c5cccc(NC(C)=O)c5)c(=O)[nH]c4=O)=C3O)C(=O)N=C2O)c1.CCC(C)(C)C(=O)/N=C1\CC(=C2C(=O)C(c3[nH]c(NC(=O)C(C)(C)CC)c(C(=O)OC4C(C(C)(C)C)CC(C)CC4C(C)(C)C)c3C(C)C)=C2O)C(C(C)C)=C1C(=O)OC1C(C(C)(C)C)CC(C)CC1C(C)(C)C.CCCCC(CC)COC1=CC(N(CCC)CCC)=CC(=O)C1=C1C(=O)C(c2c(O)cc(N(CCC)CCC)cc2OCC(CC)CCCC)=C1O.CN=C1N/C(=N\C)C(=C2C(=O)C(c3c(NCCCOC)nc(NCCCOC)nc3NCCCOC)=C2O)/C(=N/C)N1.O=C1C(=C2C=Nc3ccccc32)C(O)=C1c1c[nH]c2ccccc12
InChIInChI=1S/C63H99N3O8.C44H68N2O6.C28H20N6O10.C27H42N10O5.C20H12N2O2/c1-25-62(21,22)56(71)64-41-31-36(42(32(3)4)45(41)54(69)73-51-37(58(9,10)11)27-34(7)28-38(51)59(12,13)14)44-49(67)47(50(44)68)48-43(33(5)6)46(53(65-48)66-57(72)63(23,24)26-2)55(70)74-52-39(60(15,16)17)29-35(8)30-40(52)61(18,19)20;1-9-17-19-31(15-7)29-51-37-27-33(45(21-11-3)22-12-4)25-35(47)39(37)41-43(49)42(44(41)50)40-36(48)26-34(46(23-13-5)24-14-6)28-38(40)52-30-32(16-8)20-18-10-2;1-11(35)29-13-5-3-7-15(9-13)33-25(41)19(23(39)31-27(33)43)17-21(37)18(22(17)38)20-24(40)32-28(44)34(26(20)42)16-8-4-6-14(10-16)30-12(2)36;1-28-22-18(23(29-2)35-26(30-3)34-22)16-20(38)17(21(16)39)19-24(31-10-7-13-40-4)36-27(33-12-9-15-42-6)37-25(19)32-11-8-14-41-5;23-19-17(13-9-21-15-7-3-1-5-11(13)15)20(24)18(19)14-10-22-16-8-4-2-6-12(14)16/h32-35,37-40,51-52,65,67H,25-31H2,1-24H3,(H,66,72);25-28,31-32,47,49H,9-24,29-30H2,1-8H3;3-10,37,41H,1-2H3,(H,29,35)(H,30,36)(H,31,39,43)(H,32,40,44);38H,7-15H2,1-6H3,(H2,28,29,30,34,35)(H3,31,32,33,36,37);1-10,21,23H/b44-36?,64-41+;;20-18-;;
InChIKeyXPYFGIJFOWWOHL-FOHREUKQSA-N
MW3247.06 g/mol
LogP32.01
Rot. Bonds59

About N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one

N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one (PubChem CID 165035261) has the molecular formula C182H241N23O31 and a molecular weight of 3247.06 g/mol. Its IUPAC name is N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one.

Molecular Properties

Compound NameN-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one
PubChem CID165035261
Molecular FormulaC182H241N23O31
Molecular Weight3247.06 g/mol
Exact Mass3244.80
IUPAC NameN-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one
SMILESCC(=O)Nc1cccc(N2C(=O)/C(=C3\C(=O)C(c4c(O)n(-c5cccc(NC(C)=O)c5)c(=O)[nH]c4=O)=C3O)C(=O)N=C2O)c1.CCC(C)(C)C(=O)/N=C1\CC(=C2C(=O)C(c3[nH]c(NC(=O)C(C)(C)CC)c(C(=O)OC4C(C(C)(C)C)CC(C)CC4C(C)(C)C)c3C(C)C)=C2O)C(C(C)C)=C1C(=O)OC1C(C(C)(C)C)CC(C)CC1C(C)(C)C.CCCCC(CC)COC1=CC(N(CCC)CCC)=CC(=O)C1=C1C(=O)C(c2c(O)cc(N(CCC)CCC)cc2OCC(CC)CCCC)=C1O.CN=C1N/C(=N\C)C(=C2C(=O)C(c3c(NCCCOC)nc(NCCCOC)nc3NCCCOC)=C2O)/C(=N/C)N1.O=C1C(=C2C=Nc3ccccc32)C(O)=C1c1c[nH]c2ccccc12
InChIInChI=1S/C63H99N3O8.C44H68N2O6.C28H20N6O10.C27H42N10O5.C20H12N2O2/c1-25-62(21,22)56(71)64-41-31-36(42(32(3)4)45(41)54(69)73-51-37(58(9,10)11)27-34(7)28-38(51)59(12,13)14)44-49(67)47(50(44)68)48-43(33(5)6)46(53(65-48)66-57(72)63(23,24)26-2)55(70)74-52-39(60(15,16)17)29-35(8)30-40(52)61(18,19)20;1-9-17-19-31(15-7)29-51-37-27-33(45(21-11-3)22-12-4)25-35(47)39(37)41-43(49)42(44(41)50)40-36(48)26-34(46(23-13-5)24-14-6)28-38(40)52-30-32(16-8)20-18-10-2;1-11(35)29-13-5-3-7-15(9-13)33-25(41)19(23(39)31-27(33)43)17-21(37)18(22(17)38)20-24(40)32-28(44)34(26(20)42)16-8-4-6-14(10-16)30-12(2)36;1-28-22-18(23(29-2)35-26(30-3)34-22)16-20(38)17(21(16)39)19-24(31-10-7-13-40-4)36-27(33-12-9-15-42-6)37-25(19)32-11-8-14-41-5;23-19-17(13-9-21-15-7-3-1-5-11(13)15)20(24)18(19)14-10-22-16-8-4-2-6-12(14)16/h32-35,37-40,51-52,65,67H,25-31H2,1-24H3,(H,66,72);25-28,31-32,47,49H,9-24,29-30H2,1-8H3;3-10,37,41H,1-2H3,(H,29,35)(H,30,36)(H,31,39,43)(H,32,40,44);38H,7-15H2,1-6H3,(H2,28,29,30,34,35)(H3,31,32,33,36,37);1-10,21,23H/b44-36?,64-41+;;20-18-;;
InChIKeyXPYFGIJFOWWOHL-FOHREUKQSA-N
XLogP32.01
TPSA757.77 Ų
H-Bond Donors19
H-Bond Acceptors42
Rotatable Bonds59
Heavy Atoms236
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003247.06
LogP ≤ 532.01
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_B(251)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_4', 'substructure': 'N/A'}

Analyze N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one?
The IUPAC name of N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one (CID 165035261) is N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one.
What is the SMILES notation for N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one?
The canonical SMILES for N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one is CC(=O)Nc1cccc(N2C(=O)/C(=C3\C(=O)C(c4c(O)n(-c5cccc(NC(C)=O)c5)c(=O)[nH]c4=O)=C3O)C(=O)N=C2O)c1.CCC(C)(C)C(=O)/N=C1\CC(=C2C(=O)C(c3[nH]c(NC(=O)C(C)(C)CC)c(C(=O)OC4C(C(C)(C)C)CC(C)CC4C(C)(C)C)c3C(C)C)=C2O)C(C(C)C)=C1C(=O)OC1C(C(C)(C)C)CC(C)CC1C(C)(C)C.CCCCC(CC)COC1=CC(N(CCC)CCC)=CC(=O)C1=C1C(=O)C(c2c(O)cc(N(CCC)CCC)cc2OCC(CC)CCCC)=C1O.CN=C1N/C(=N\C)C(=C2C(=O)C(c3c(NCCCOC)nc(NCCCOC)nc3NCCCOC)=C2O)/C(=N/C)N1.O=C1C(=C2C=Nc3ccccc32)C(O)=C1c1c[nH]c2ccccc12.
What is the InChIKey of N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one?
The InChIKey is XPYFGIJFOWWOHL-FOHREUKQSA-N. The full InChI is InChI=1S/C63H99N3O8.C44H68N2O6.C28H20N6O10.C27H42N10O5.C20H12N2O2/c1-25-62(21,22)56(71)64-41-31-36(42(32(3)4)45(41)54(69)73-51-37(58(9,10)11)27-34(7)28-38(51)59(12,13)14)44-49(67)47(50(44)68)48-43(33(5)6)46(53(65-48)66-57(72)63(23,24)26-2)55(70)74-52-39(60(15,16)17)29-35(8)30-40(52)61(18,19)20;1-9-17-19-31(15-7)29-51-37-27-33(45(21-11-3)22-12-4)25-35(47)39(37)41-43(49)42(44(41)50)40-36(48)26-34(46(23-13-5)24-14-6)28-38(40)52-30-32(16-8)20-18-10-2;1-11(35)29-13-5-3-7-15(9-13)33-25(41)19(23(39)31-27(33)43)17-21(37)18(22(17)38)20-24(40)32-28(44)34(26(20)42)16-8-4-6-14(10-16)30-12(2)36;1-28-22-18(23(29-2)35-26(30-3)34-22)16-20(38)17(21(16)39)19-24(31-10-7-13-40-4)36-27(33-12-9-15-42-6)37-25(19)32-11-8-14-41-5;23-19-17(13-9-21-15-7-3-1-5-11(13)15)20(24)18(19)14-10-22-16-8-4-2-6-12(14)16/h32-35,37-40,51-52,65,67H,25-31H2,1-24H3,(H,66,72);25-28,31-32,47,49H,9-24,29-30H2,1-8H3;3-10,37,41H,1-2H3,(H,29,35)(H,30,36)(H,31,39,43)(H,32,40,44);38H,7-15H2,1-6H3,(H2,28,29,30,34,35)(H3,31,32,33,36,37);1-10,21,23H/b44-36?,64-41+;;20-18-;;.
What are the key properties of N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one?
N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one has a molecular weight of 3247.06 g/mol, XLogP of 32.01, 59 rotatable bonds, 19 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[5-[(3Z)-3-[1-(3-acetamidophenyl)-2-hydroxy-4,6-dioxopyrimidin-5-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-6-hydroxy-2,4-dioxopyrimidin-1-yl]phenyl]acetamide;(2,6-ditert-butyl-4-methylcyclohexyl) 5-[3-[3-(2,6-ditert-butyl-4-methylcyclohexyl)oxycarbonyl-4-(2,2-dimethylbutanoylimino)-2-propan-2-ylcyclopent-2-en-1-ylidene]-2-hydroxy-4-oxocyclobuten-1-yl]-2-(2,2-dimethylbutanoylamino)-4-propan-2-yl-1H-pyrrole-3-carboxylate;3-(dipropylamino)-6-[3-[4-(dipropylamino)-2-(2-ethylhexoxy)-6-hydroxyphenyl]-2-hydroxy-4-oxocyclobut-2-en-1-ylidene]-5-(2-ethylhexoxy)cyclohexa-2,4-dien-1-one;3-hydroxy-2-(1H-indol-3-yl)-4-indol-3-ylidenecyclobut-2-en-1-one;3-hydroxy-2-[2,4,6-tris(3-methoxypropylamino)pyrimidin-5-yl]-4-[2,4,6-tris(methylimino)-1,3-diazinan-5-ylidene]cyclobut-2-en-1-one is sourced from PubChem (CID 165035261), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).